Page last updated: 2024-11-07

bromfenvinphos

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

bromfenvinphos: RN given refers to cpd without isomeric designation; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID6108489
SCHEMBL ID3726418
MeSH IDM0062853

Synonyms (23)

Synonym
o,o-dwuetylo-o-1-(2,4-dwuchlorofenylo)-2-bromowinylofosforan [polish]
bromfenwinfos [polish]
phosphoric acid, 2-bromo-1-(2,4-dichlorophenyl)vinyl diethyl ester
ccris 2702
ipo 62
bromfenvinphos
o-1-(2,4-dichlorophenyl)-2-bromovinyl o,o-diethyl phosphate
ipophos
bromfenvinfos
phosphoric acid, 2-bromo-1-(2,4-dichlorophenyl)ethenyl diethyl ester
bromphenvinphos
bromfenvinphos [iso]
sd 8989
ipofos [polish]
o,o-dwuetylo-o-1-(2,4-dwuchlorofenylo)-2-bromowinylofosforan
ipofos
bromfenwinfos
bromfenvinphos-ethyl
SCHEMBL3726418
ORDKAVSHIKNMAN-XYOKQWHBSA-N
bromfenvinphos-ethyl, pestanal(r), analytical standard
J-019175
Q9179588
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (22)

TimeframeStudies, This Drug (%)All Drugs %
pre-199014 (63.64)18.7374
1990's2 (9.09)18.2507
2000's1 (4.55)29.6817
2010's5 (22.73)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other27 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]